Company News: Sanofi-Aventis and Warner Chilcott

Share this article:
Sanofi-Aventis handed over Actonel marketing rights in the US to its collaborator on the drug, Warner Chilcott. Under the new agreement, Warner Chilcott will take full operational control over promotion, marketing and R&D decisions in the US and Puerto Rico. As part of the deal, Warner Chilcott will offer "a number of sales reps currently promoting Actonel for Sanofi-Aventis" jobs on the Warner Chilcott sales force, according to a company statement.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions